NO20005797D0 - Nye aminopyrrolinforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem - Google Patents

Nye aminopyrrolinforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem

Info

Publication number
NO20005797D0
NO20005797D0 NO20005797A NO20005797A NO20005797D0 NO 20005797 D0 NO20005797 D0 NO 20005797D0 NO 20005797 A NO20005797 A NO 20005797A NO 20005797 A NO20005797 A NO 20005797A NO 20005797 D0 NO20005797 D0 NO 20005797D0
Authority
NO
Norway
Prior art keywords
alkyl
compounds
aminopyrroline
aryl
novel
Prior art date
Application number
NO20005797A
Other languages
English (en)
Other versions
NO20005797L (no
NO317987B1 (no
Inventor
Pascal Bousquet
Jean-Daniel Ehrhardt
Veronique Bruban
Josiane Feldman
Stephan Schann
Elizabeth Scalbert
Bruno Pfeiffer
Pierre Renard
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of NO20005797D0 publication Critical patent/NO20005797D0/no
Publication of NO20005797L publication Critical patent/NO20005797L/no
Publication of NO317987B1 publication Critical patent/NO317987B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/40—Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
NO20005797A 1999-11-17 2000-11-16 Nye aminopyrrolinforbindelser, fremgangsmate ved deres fremstilling og farmasoytiske sammensetninger inneholdende dem NO317987B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9914434A FR2801051B1 (fr) 1999-11-17 1999-11-17 Nouveaux composes aminopyrroline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (3)

Publication Number Publication Date
NO20005797D0 true NO20005797D0 (no) 2000-11-16
NO20005797L NO20005797L (no) 2001-05-18
NO317987B1 NO317987B1 (no) 2005-01-17

Family

ID=9552203

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005797A NO317987B1 (no) 1999-11-17 2000-11-16 Nye aminopyrrolinforbindelser, fremgangsmate ved deres fremstilling og farmasoytiske sammensetninger inneholdende dem

Country Status (22)

Country Link
US (1) US6300366B1 (no)
EP (1) EP1101756B1 (no)
JP (1) JP3274456B2 (no)
KR (1) KR100453981B1 (no)
CN (1) CN1158257C (no)
AT (1) ATE234815T1 (no)
AU (1) AU771745B2 (no)
BR (1) BR0005442A (no)
CA (1) CA2325781C (no)
DE (1) DE60001706T2 (no)
DK (1) DK1101756T3 (no)
EA (1) EA004042B1 (no)
ES (1) ES2194691T3 (no)
FR (1) FR2801051B1 (no)
HU (1) HUP0004543A3 (no)
MX (1) MXPA00011239A (no)
NO (1) NO317987B1 (no)
NZ (1) NZ508228A (no)
PL (1) PL343920A1 (no)
PT (1) PT1101756E (no)
SI (1) SI1101756T1 (no)
ZA (1) ZA200006731B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1517688A2 (de) 2002-06-19 2005-03-30 Solvay Pharmaceuticals GmbH Arzneimittel zur behandlung von eine inhibition oder aktivitätsverminderung von ph-wert-regulierenden bikarbonat-transporter-proteinen erfordernden erkrangungen
GB0521083D0 (en) * 2005-10-17 2005-11-23 Novartis Ag Organic compounds
KR20160042039A (ko) 2013-08-09 2016-04-18 알데릭스, 인코포레이티드 인산염 수송을 억제하기 위한 화합물 및 방법
GB201318886D0 (en) * 2013-10-25 2013-12-11 Givaudan Sa Improvements i or relating to organic compounds
CN114716359B (zh) * 2022-04-28 2023-01-17 广东医科大学 一种氢化吲哚亚胺非对映异构体的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2029297A1 (de) * 1970-06-13 1971-12-30 Farbenfabriken Bayer Ag, 5090 Leverkusen Neue Aminophenyl-cycloamidine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US3887569A (en) * 1970-10-30 1975-06-03 Mcneilab Inc 2-Imino-piperidines
NL7412695A (nl) * 1974-09-26 1976-03-30 Stamicarbon De bereiding van een 2-amino-pyrrolinederivaat.
US4579951A (en) * 1984-03-19 1986-04-01 G. D. Searle & Co. Substituted (azacycloalk-2-yl)iminophenols and esters thereof
DE4425070A1 (de) * 1994-07-15 1996-01-18 Degussa Verfahren zur Herstellung optisch aktiver l-substituierter 2-(Aminomethyl)pyrrolidine

Also Published As

Publication number Publication date
AU771745B2 (en) 2004-04-01
CA2325781A1 (fr) 2001-05-17
JP2001139545A (ja) 2001-05-22
KR20010051776A (ko) 2001-06-25
EA004042B1 (ru) 2003-12-25
JP3274456B2 (ja) 2002-04-15
CN1158257C (zh) 2004-07-21
HUP0004543A3 (en) 2001-11-28
US6300366B1 (en) 2001-10-09
HUP0004543A2 (hu) 2001-10-28
HU0004543D0 (no) 2001-02-28
SI1101756T1 (en) 2003-06-30
MXPA00011239A (es) 2002-05-23
DE60001706T2 (de) 2004-02-05
ES2194691T3 (es) 2003-12-01
NO20005797L (no) 2001-05-18
DE60001706D1 (de) 2003-04-24
CA2325781C (fr) 2006-07-18
EA200001077A2 (ru) 2001-06-25
DK1101756T3 (da) 2003-07-14
BR0005442A (pt) 2001-07-03
EP1101756B1 (fr) 2003-03-19
ATE234815T1 (de) 2003-04-15
KR100453981B1 (ko) 2004-10-20
AU7168000A (en) 2001-05-24
PT1101756E (pt) 2003-06-30
PL343920A1 (en) 2001-05-21
ZA200006731B (en) 2001-05-30
EA200001077A3 (ru) 2001-08-27
FR2801051A1 (fr) 2001-05-18
CN1298872A (zh) 2001-06-13
NZ508228A (en) 2001-03-30
EP1101756A1 (fr) 2001-05-23
HK1036454A1 (en) 2002-01-04
FR2801051B1 (fr) 2001-12-14
NO317987B1 (no) 2005-01-17

Similar Documents

Publication Publication Date Title
DK1005465T3 (da) Nye epothilon-derivater, fremgangsmåde til fremstilling heraf og deres farmaceutiske anvendelse
AR034268A1 (es) Compuestos derivados de piperidina, su uso en preparacion de medicamentos, composicion farmaceutica, metodo de tratamiento y proceso para su preparacion
TW200724136A (en) Pharmaceutical compositions comprising PPAR modulator
PE20040155A1 (es) Derivados aminoinazoles, procedimiento de preparacion e intermedios de este procedimiento a titulo de medicamentos y composiciones farmaceuticas que los contienen
KR950014097A (ko) 피페라진 유도체
SE9702799D0 (sv) New compounds
HUP9802694A1 (hu) Benzamidszármazékok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények
ES2162466T3 (es) Derivados de 1,2,4-triazolo(4,3-b)pirido(3,2-d)piridazina y composiciones farmaceuticas que los contienen.
SE0101579D0 (sv) New compounds
ATE482933T1 (de) Sulfopyrrolderivate
NO20005797L (no) Nye aminopyrrolinforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
HUP0201475A2 (hu) Heteroarilamidin-, metilamidin- és guanidinszármazékok, előállításuk és alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények
DK1103554T3 (da) Dihydrofuro-[3,4-b]quinolein-1-onderivater, fremgangsmåde til fremstilling deraf og farmaceutiske sammensætninger, som indeholder dem
DE60205265D1 (de) 1-glyoxlylamidindolizine zur behandlung von krebs
CY1105666T1 (el) Διεργασια για την παρασκευη αζακυκλοαλκανοϋλαμινοθειαζολων
TW200510309A (en) Chemical compounds
AR002715A1 (es) Derivados de piperazina y piperazinona heterociclos substituidos particularmente utiles como antagonistas de los receptores de taquikinina,composicion farmaceutica que incluye uno de dichos derivados, uso de dichos compuestos en la preparacion de las composiciones y procedimiento para la preparacion de los derivados
NO985239L (no) Nye metalloproteinase inhibitorer, fremgangsmÕte ved deres fremstilling og farmas°ytiske sammensetninger inneholdende dem
DK0841337T3 (da) Substituerede 7,12-dioxabenzo[a]anthracenderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger, der indeholder disse derivater
NO955071D0 (no) abeo-Ergolin-derivater som 5HT1A-ligander
MXPA04011363A (es) Nuevos derivados acil hidrazino del tiofeno, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas y nueva utilizacion.
MXPA03010597A (es) Derivados de triciclicos de dihidroquinolinas proceso para prepararlos y composiciones farmaceuticas que los contienen.
NO993608D0 (no) Nye 8H-tieno-[2,3-b]pyrrolizin-8-on forbindelser, fremgangsmåte ved deres fremstilling og farmasoeytiske sammensetninger inneholdende dem